• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MYnd Analytics, Carolina Partners to launch personalized mental health program

MYnd Analytics, Carolina Partners to launch personalized mental health program

November 21, 2016
CenterWatch Staff

MYnd Analytics and Carolina Partners in Mental Healthcare are teaming up to provide personalized care to veterans and civilians seeking quality evidence based mental health care. Carolina Partners, a 25 clinic outpatient psychiatry group practice based in Durham, N.C., is the first non-governmental site to launch the SMART-MD protocol for Veterans. This randomized, double-blind, multi-site clinical study will enroll patients—including veterans, active service members and their families—with a primary diagnosis of depression. 

Carolina Partners executed a PEER Services agreement which provides access to PEER for clinicians in all of its locations.

“At Carolina Partners, we empower our providers with information,” said Stan Monroe, Carolina Partners CEO. “Utilizing PEER and participating in the SMART-MD trial keeps our doctors on the cutting edge of evidence-based care and brings our patients the best quality care.”

“Our mission is to assist physicians in selecting the best targeted treatment for each patient, and with Carolina Partners, we're teaming up with a leader in evidence-based care," said George Carpenter, MYnd Analytics CEO.

PEER is a predictive medicine technology developed by MYND which combines an EEG scan of brain function with the largest registry of long-term outcomes in the world to assist physicians in selecting the medication which is most likely to work on a specific patient’s brain. A recently released military trial showed a reduction in suicidality by over 75% when physicians followed PEER recommendations, 2.5 times greater adherence to PEER-recommended therapy by patients, and three times higher medication efficacy than physicians treating as usual without the benefit of PEER.

“Studies continue to confirm the value of PEER information, and we look forward to working with Carolina Partners and rolling the technology out to more providers in the U.S. and Canada,” said Carpenter.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing